目的:研究新合成产物乙酰半胱氨酸镁盐-甘草酸环状样二聚体(acetylcysteine magnesiumglycyrrhizin fine antipode dimers,GFA-NAC·Mg)治疗大鼠肝纤维化的效果。方法:25%四氯化碳(CCl4)制备大鼠肝纤维化模型,GFA-NAC·Mg按25...目的:研究新合成产物乙酰半胱氨酸镁盐-甘草酸环状样二聚体(acetylcysteine magnesiumglycyrrhizin fine antipode dimers,GFA-NAC·Mg)治疗大鼠肝纤维化的效果。方法:25%四氯化碳(CCl4)制备大鼠肝纤维化模型,GFA-NAC·Mg按25、50、100mg/kg剂量每日分别腹腔注射进行肝纤维化治疗,给药8周后处死大鼠,用肝纤维化网格染色观察肝纤维化情况,ELISA法测定血清羟脯氨酸(Hyp)和肝组织丙二醛(MDA)、超氧化物歧化酶(SOD)、转化生长因子-β1(TGF-β1)、血小板衍生生长因子(PDGF)。结果:大鼠肝组织病理结果显示其肝纤维化处于Ⅲ-Ⅳ期;与模型组比较,GFA-NAC·Mg治疗后血清Hyp明显降低;肝组织抗氧化指标SOD显著升高,MDA明显下降;肝纤维化指标TGF-β1、PDGF在组织含量下降;GFA-NAC·Mg各组网格染色显示肝纤维化好转。结论:GFA-NAC·Mg对肝纤维化大鼠有较好实验治疗作用,可能通过抑制PDGF和TGF-β1的表达而实现。展开更多
The interaction between citrate capped silver nanoparticles and two different thiols, mercaptohexanol （MH） and cysteine, was investigated. The thiols interacted with silver nanoparticles in a significantly contrasti...The interaction between citrate capped silver nanoparticles and two different thiols, mercaptohexanol （MH） and cysteine, was investigated. The thiols interacted with silver nanoparticles in a significantly contrasting manner. With MH, a sparingly soluble silver（1） thiolate complex AgSRm （Rm = -（CH2）6OH） was formed on the silver nanoparticle surface. Cyclic voltammograms and UV-vis spectra were used to infer that the AgSRm complex on the nanoparticle surface undergoes a phase transition to give a mixture of AgSRm and Ag2S-like complexes. In contrast, when silver nanoparticles were exposed to cysteine, the citrate cap- ping agent on the silver nanoparticles was replaced by cysteine to give cysteine capped nanoparticles. As cysteine capped nanoparticles form, the electrochemical data displayed a decrease in oxidative peak charge but the UV-vis spectra showed a constant signal. Therefore, cysteine capped nanoparticles were suggested to have either inactivated the silver surface or else pro- moted detachment from the electrode surface.展开更多
文摘目的:研究新合成产物乙酰半胱氨酸镁盐-甘草酸环状样二聚体(acetylcysteine magnesiumglycyrrhizin fine antipode dimers,GFA-NAC·Mg)治疗大鼠肝纤维化的效果。方法:25%四氯化碳(CCl4)制备大鼠肝纤维化模型,GFA-NAC·Mg按25、50、100mg/kg剂量每日分别腹腔注射进行肝纤维化治疗,给药8周后处死大鼠,用肝纤维化网格染色观察肝纤维化情况,ELISA法测定血清羟脯氨酸(Hyp)和肝组织丙二醛(MDA)、超氧化物歧化酶(SOD)、转化生长因子-β1(TGF-β1)、血小板衍生生长因子(PDGF)。结果:大鼠肝组织病理结果显示其肝纤维化处于Ⅲ-Ⅳ期;与模型组比较,GFA-NAC·Mg治疗后血清Hyp明显降低;肝组织抗氧化指标SOD显著升高,MDA明显下降;肝纤维化指标TGF-β1、PDGF在组织含量下降;GFA-NAC·Mg各组网格染色显示肝纤维化好转。结论:GFA-NAC·Mg对肝纤维化大鼠有较好实验治疗作用,可能通过抑制PDGF和TGF-β1的表达而实现。
基金supported by the National Research Foundation Singapore under its National Research Foundation(NRF)Environmental and Water Technologies(EWT)PhD Scholarship Programme and administered by the Environment and Water Industry Programme Office(EWI)supported by a Marie Curie Intra European Fellowshipfunding from the European Union’s Seventh Framework Programme(FP/2007-2013)/ERC Grant Agreement n.[320403]
文摘The interaction between citrate capped silver nanoparticles and two different thiols, mercaptohexanol （MH） and cysteine, was investigated. The thiols interacted with silver nanoparticles in a significantly contrasting manner. With MH, a sparingly soluble silver（1） thiolate complex AgSRm （Rm = -（CH2）6OH） was formed on the silver nanoparticle surface. Cyclic voltammograms and UV-vis spectra were used to infer that the AgSRm complex on the nanoparticle surface undergoes a phase transition to give a mixture of AgSRm and Ag2S-like complexes. In contrast, when silver nanoparticles were exposed to cysteine, the citrate cap- ping agent on the silver nanoparticles was replaced by cysteine to give cysteine capped nanoparticles. As cysteine capped nanoparticles form, the electrochemical data displayed a decrease in oxidative peak charge but the UV-vis spectra showed a constant signal. Therefore, cysteine capped nanoparticles were suggested to have either inactivated the silver surface or else pro- moted detachment from the electrode surface.
